Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Efficacy of Novel Agents in Multiple Myeloma in Comparison to Autologous Stem Cell Transplant: A Retrospective Study in a Single Inner City Institution

Tareq Braik, MD, Dayra Avila, MD, Shivi Jain, MD, Manila Gaddh, MD, Barabara Yim, PharmD, Peter Ruestow, MPH, Shylendra B Sreenivasappa, MD, Shweta Gupta, MD, Sylvia Velinova, MD, Paul G. Rubinstein, MD, Margaret Telfer, MD, Mousami Shah, MD, Thomas Lad, Rosalind Catchatourian, MD

Blood (2011) 118 (21): 5118.

https://doi.org/10.1182/blood.V118.21.5118.5118

Published: 2011

Journal Articles

Efficacy of RICE as Second Line Chemotherapy in Transplant Ineligible Patients with Diffuse Large B Cell Lymphoma: a Single Institution Experience.

Mousami Shah, Shylendra B Sreenivasappa, MD, Barbara Yim, Pharm, D, Bety Ciobanu, MD, Rosalind Catchatourian, MD

Blood (2009) 114 (22): 4757.

https://doi.org/10.1182/blood.V114.22.4757.4757

Published: 2009

Journal Articles

Response of Patients with Aggressive Non Hodgkin's Gastro Intestinal Tract Lymphoma to Upfront Rituximab Based Chemotherapy: A Single Institution Experience.

Bety Ciobanu, MD, Shylendra B Sreenivasappa, MD, Mousami Shah, Barbara Yim, Pharm, D, Rosalind Catchatourian, MD

Blood (2009) 114 (22): 4791.

https://doi.org/10.1182/blood.V114.22.4791.4791

Published: 2009

Journal Articles

Clinical Presentation, Risk Profiles and Outcomes of Chemotherapy without Bone Marrow Transplant in a Cohort of Minority Patients with Acute Lymphoblastic Leukemia from a Public Health Hospital

Bety Ciobanu, MD, Shylendra B Sreenivasappa, MD, Tracy Smiley, RN, Barbara Yim, Pharm.D, Paula Kovarik, MD, Mousami Shah, MD, Rafid Kouz, MD, Samuel Ofori, MD, Margaret Clare Telfer, MD, Rosalind Catchatourian, MD

Blood (2008) 112 (11): 3958.

https://doi.org/10.1182/blood.V112.11.3958.3958

Published: 2008

Journal Articles

Fludarabine Combination Therapy Response, Progression and Toxicity Profile in a Minority Predominant Population with Chronic Lymphocytic Leukemia from a Public Health Hospital

Bety Ciobanu, MD, Shylendra B Sreenivasappa, MD, Barbara Yim, Pharm.D, Tracy Smiley, RN, Victoria Angelova, MD, Paula Kovarik, MD, Samuel Ofori, MD, Mousami Shah, MD, Rafid Kouz, MD, Margaret Clare Telfer, MD, Rosalind Catchatourian, MD

Blood (2008) 112 (11): 4213.

https://doi.org/10.1182/blood.V112.11.4213.4213

Published: 2008

Journal Articles

Presentation Characteristics, Risk Profiles and Response to Thalidomide in a Public Health System, Minority Patient Population with Multiple Myeloma

Shylendra B Sreenivasappa, MD, Mousami Shah, MD, Rosalind Catchatourian, MD, Luciano Fochesatto, MD, Barbara Yim, Pharm.D

Blood (2008) 112 (11): 5189.

https://doi.org/10.1182/blood.V112.11.5189.5189

Published: 2008

NARROW

Efficacy of Novel Agents in Multiple Myeloma in Comparison to Autologous Stem Cell Transplant: A Retrospective Study in a Single Inner City Institution

Efficacy of RICE as Second Line Chemotherapy in Transplant Ineligible Patients with Diffuse Large B Cell Lymphoma: a Single Institution Experience.

Response of Patients with Aggressive Non Hodgkin's Gastro Intestinal Tract Lymphoma to Upfront Rituximab Based Chemotherapy: A Single Institution Experience.

Clinical Presentation, Risk Profiles and Outcomes of Chemotherapy without Bone Marrow Transplant in a Cohort of Minority Patients with Acute Lymphoblastic Leukemia from a Public Health Hospital

Fludarabine Combination Therapy Response, Progression and Toxicity Profile in a Minority Predominant Population with Chronic Lymphocytic Leukemia from a Public Health Hospital

Presentation Characteristics, Risk Profiles and Response to Thalidomide in a Public Health System, Minority Patient Population with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Efficacy of Novel Agents in Multiple Myeloma in Comparison to Autologous Stem Cell Transplant: A Retrospective Study in a Single Inner City Institution

Efficacy of RICE as Second Line Chemotherapy in Transplant Ineligible Patients with Diffuse Large B Cell Lymphoma: a Single Institution Experience.

Response of Patients with Aggressive Non Hodgkin's Gastro Intestinal Tract Lymphoma to Upfront Rituximab Based Chemotherapy: A Single Institution Experience.

Clinical Presentation, Risk Profiles and Outcomes of Chemotherapy without Bone Marrow Transplant in a Cohort of Minority Patients with Acute Lymphoblastic Leukemia from a Public Health Hospital

Fludarabine Combination Therapy Response, Progression and Toxicity Profile in a Minority Predominant Population with Chronic Lymphocytic Leukemia from a Public Health Hospital

Presentation Characteristics, Risk Profiles and Response to Thalidomide in a Public Health System, Minority Patient Population with Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only